Literature DB >> 171681

Fluorescent virus precipitin test.

L G Foster, M W Peterson, R S Spendlove.   

Abstract

A fluorescent virus precipitin test (FVPT) for the serologic identification of small particulate antigens such as viruses has been described. The test has several advantageous characteristics: (a) It is probably as sensitive as any serologic test (i.e., aggregates with dimensions of 0.2 mum are detectable; therefore, complexes containing as few as three large viruses would give a positive test). (b) Cultivation of the virus is not required. (c) Since an indirect test can be used, only a single fluorescent conjugate is needed to permit the detection of a number of viruses. (d) The indirect test can be used to detect antiviral antibody. (e) The FVPT is rapid and reliable. (f) Its simplicity should enhance its general acceptance and application.

Mesh:

Substances:

Year:  1975        PMID: 171681     DOI: 10.3181/00379727-150-38994

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  4 in total

1.  Enzyme-linked immunosorbent assay for diagnosis of rotavirus infections in calves.

Authors:  D J Ellens; P W de Leeuw
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

2.  Comparison of Counterimmunoelectrophoresis and electron microscopy for laboratory diagnosis of human reovirus-like agent-associated infantile gastroenteritis.

Authors:  L Spence; M Fauvel; R Petro; S Bloch
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

3.  Detection of neonatal calf diarrhea virus, infant reovirus-like diarrhea virus, and a coronavirus using the fluorescent virus precipitin test.

Authors:  M W Peterson; R S Spendlove; R A Smart
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

4.  Use of a free viral immunofluorescence assay to detect human reovirus-like agent in human stools.

Authors:  R H Yolken; R G Wyatt; A R Kalica; H W Kim; C D Brandt; R H Parrott; A Z Kapikian; R M Chanock
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.